Establishment Labs Holdings Inc
F:3E0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Establishment Labs Holdings Inc
F:3E0
|
CR |
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AIL
|
FR |
|
G
|
Goldman Sachs BDC Inc
F:GSB
|
US |
|
D
|
Dolby Laboratories Inc
XMUN:FUO
|
US |
|
Vaxart Inc
OTC:VXRT
|
US |
Wall St Price Targets
Price Targets Summary
Establishment Labs Holdings Inc
According to Wall Street analysts, the average 1-year price target for Establishment Labs Holdings Inc is 45.15 EUR with a low forecast of 36.88 EUR and a high forecast of 50.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Establishment Labs Holdings Inc's stock price target?
Price Target
45.15
EUR
According to Wall Street analysts, the average 1-year price target for Establishment Labs Holdings Inc is 45.15 EUR with a low forecast of 36.88 EUR and a high forecast of 50.45 EUR.
What is the Revenue forecast for Establishment Labs Holdings Inc?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 3 years is 26%.
What is the Gross Profit forecast for Establishment Labs Holdings Inc?
Projected CAGR
30%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 35%. The projected CAGR for the next 3 years is 30%.
